Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Inovio Slumps as Its Setbacks Pile Up

By Ian Bezek, InvestorPlace Contributor

Between the government snubbing Inovio's vaccine and a legal dispute, INO stock is running into mounting headwinds.

Virgin Galactic Stock Won’t Benefit Now From SpaceX’s Success

By Ian Bezek, InvestorPlace Contributor

The private spaceflight era is now upon us. SpaceX's advances, however, don't make Virgin Galactic or SPCE stock any more appealing.

Wells Fargo Is a Compelling Bargain Buy

By Ian Bezek, InvestorPlace Contributor

While investors in Wells Fargo stock are rightly nervous about earnings and dividend safety in 2020, patience will be rewarded.

Leave J.C. Penney Stock in the Clearance Bin

By Ian Bezek, InvestorPlace Contributor

Traders shouldn't bet on a recovery at J.C. Penney. The current bankruptcy process is overwhelmingly likely to leave the current stock worthless.

High-Quality Company Sherwin-Williams Is a Buy on Dips

By Ian Bezek, InvestorPlace Contributor

With the recent rebound, Sherwin-Williams stock is no longer a bargain. But the company is still worth of being on your radar.

Let the Economy Settle Before Buying Ford

By Ian Bezek, InvestorPlace Contributor

Auto sales will be down sharply throughout 2020. This means that it's too early to buy the dip in F stock right now.

MGM Resorts Is Worth a Roll of the Dice

By Ian Bezek, InvestorPlace Contributor

With Las Vegas soon reopening, a critical headwind against MGM stock will fade away, inviting the risky but compelling bullish trade.

AbbVie Will Be in Big Trouble When Its Patent Cliff Arrives

By Ian Bezek, InvestorPlace Contributor

ABBV stock may seem like an attractive value name. But while it is very profitable now, things are set to worsen dramatically in a few years..

As Competition Heats up, Sell Beyond Meat Stock Above $100 While You Can

By Ian Bezek, InvestorPlace Contributor

Beyond Meat stock will slump as rising competition threatens profits. Meanwhile, the coronavirus sales surge will fade.

Don’t Hold Onto the Junior Gold Miners ETF for Too Long

By Ian Bezek, InvestorPlace Contributor

Direxion recently reduced the leverage ratio of JNUG stock from 300% to 200%. But the shares are still too risky for investors.

Load More